Status:
COMPLETED
Integration of DBT Skills and Parent Training for Parents With a History of Substance Use
Lead Sponsor:
University of Oregon
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Parenting
Substance Abuse Relapse
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This treatment development study is aimed at developing and pilot testing a 20-week remotely delivered group intervention that integrates two evidence-based treatments: 1) Dialectical Behavior Therapy...
Detailed Description
Overview This treatment development study is aimed at developing and pilot testing a 20-week remotely delivered group intervention that integrates two evidence-based treatments: 1) Dialectical Behavi...
Eligibility Criteria
Inclusion
- Participants must reside in Oregon.
- Participants must have at least partial custody of a preschool-aged child (3-6 years)
- Participants must present elevated levels of emotion dysregulation on the Difficulties with Emotion Regulation Scale (DERS) (a score of \>88, equivalent to +.5 SD above a normative score) on the online screener.
- Participants must endorse 2 or more positive answers on adapted version of the CAGE-AID screener for drug and alcohol problems, which asks about substance use in the past 5 years.
- Participants must meet diagnostic criteria for a past (past 5 years) but not current (past 12 months) substance use disorder (SUD) from the following DSM 5 defined disorders: alcohol, cannabis, hallucinogenic, inhalant, opioid, sedative/hypnotic/anxiolytic, and stimulant.
- Participants must be proficient in English.
- Participants must have the internet access needed to participate in an online remote telehealth intervention.
Exclusion
- Participants will be excluded if they or their child have a known developmental disability or if during the clinical intake parents are determined to have a low IQ score (IQ\<70) on the PPVT-V.
- Participants will be excluded if they are psychotic as determined by the SCID 5.
- Participants will be excluded if they are actively manic or psychotic as determined by clinical observation.
- Participants will be excluded if they are actively suicidal with an active plan as determined by the SCID 5 and/or Patient Health Questionnaire 9 (PHQ-9).
- Participants will be excluded if they are determined by clinical judgment to be at high risk of violence towards others.
- Participants may be excluded if clinical judgment suggests they requires a higher level or different form of care.
Key Trial Info
Start Date :
July 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05287178
Start Date
July 12 2021
End Date
August 22 2022
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oregon
Eugene, Oregon, United States, 97403